LDCT in COVID-19 Pneumonia: a Prospective Moscow Study
LDCTiP
Low-dose Computed Tomography in COVID-19 Pneumonia: a Prospective Moscow Study
1 other identifier
interventional
230
1 country
1
Brief Summary
Hypothesis: low-dose chest computed tomography, has the same accuracy for the diagnosis of pneumonia compared to the routine protocol. In total, 230 patients are planned to be enrolled in the study. Each patient will have 2 studies (routine chest CT and low-dose chest CT) sequentially during one visit to the computed tomography room.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 25, 2020
CompletedFirst Submitted
Initial submission to the registry
April 30, 2020
CompletedFirst Posted
Study publicly available on registry
May 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2020
CompletedJune 12, 2020
May 1, 2020
27 days
April 30, 2020
June 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate the correlation between standard CT and low-dose CT scans for the detection of community-acquired pneumonia.
A standardized scale CT1-CT4 will be used. The expected correlation percentage is 90%.
Upon completion, up to 1 year
Secondary Outcomes (2)
Threshold value of the infiltration zone size detected by low-dose CT scan compared to standard CT scan.
Upon completion, up to 1 year
Number of infiltration zones of pulmonary parenchyma corresponding to viral pneumonia detected by low-dose CT scan in comparison with standard CT scan.
Upon completion, up to 1 year
Study Arms (2)
Standard Chest CT
ACTIVE COMPARATORLow-dose Chest CT
EXPERIMENTALInterventions
Patients referred by the primary care physician with suspected pneumonia.
Eligibility Criteria
You may qualify if:
- A referral from the attending physician for a chest CT scan
- Suspected pneumonia
- Signed informed consent
- Over 18 years old
- Both male and female
You may not qualify if:
- Pregnant or nursing women
- Presence of foreign implanted objects in the body at the scan level (including cardiac pacemakers, spine metalware)
- Patients after surgical intervention at the level of the chest organs
- Cancer patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Victor Gombolevskiy
Moscow, 109029, Russia
Related Publications (1)
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
PMID: 31986264BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Research Officer
Study Record Dates
First Submitted
April 30, 2020
First Posted
May 7, 2020
Study Start
April 25, 2020
Primary Completion
May 22, 2020
Study Completion
May 22, 2020
Last Updated
June 12, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share